The congenital idiopathic clubfoot (CICF) is one of the most common serious birth defect of human bones and joints. Deformity leads to downward spiral of disability, dependency and demoralization. The Ponseti technique has become the standard for treatment of congenital clubfoot in the last 2 decades and a triumph in the very complex field of management of congenital idiopathic clubfoot. In this clinical study, our main aim is to evaluate necessity of the Ponseti treatment protocol in a timely, safe, effective & sustainable manner. In this clinical trial, 621 patients (with a total 1033 feet) of 00 (from birth) to 36 months of age were selected as the study population since October, 2009. Most of them were male children (71.3%) and majority were in >03-06 months of age group. In most of the patients (about 92%), only 05 serial plasters were found to be effective & quite sufficient, whereas, only in 5.3% patients, 06-07 plasters were required followed by 1.7% patients requiring more than 07 plasters. In this study, 06 resistant cases were found where correction was relatively slower than others, but no case of treatment failure was identified. The Mid foot score (MS) found to fall greatly in plaster phases and at the end of 5h plaster it was significantly lower (0.2), whereas, in case of the Hind foot score (HS), it declined rapidly following the percutaneous tenotomy (0.2) Then the total score (TS) trends to fall to near 0, at the end of 3rd post SFAB (Steenbeek Foot Abduction Brace) routine follow up and is maintained thereafter. Approximately 74. 1% patients ultimately required tenotomy of Tendo Achilles as a part of management and the rate was highest (83.6%) in >30-36 months age group, followed by 80.0% in >24-30 months age group. The relapse rate was estimated within post SFAB routine follow up, 1.9% was within 1st 6 months & 2-1% within 6 12 months after removal of bracing. All steps in all patients were done as day case procedures. No cases of posterior-medial release was required, as like the conventional or the original Ponseti treatment protocol, hence found cost effective to the patients with excellent patient's compliance (P<0.01)Bang Med J (Khulna) 2015; 48 : 11-15
An area of loss of scalp could be covered by various methods including local flap, distant flaps, skin graft, free flap surgery or tissue expansion. Each method has some disadvantages, such as postoperative alopecia or donor site morbidities. The study was conducted in the Department of Burn and Plastic Surgery, Khulna Medical College Hospital from July 2011 to June 2015. Scalp reconstruction was performed on 16 patients who sustained scalp loss from RTA, surgery for cancer, burn injuries and machinery injury. The size of the wound ranged from 6 cm2 to 320 cm2. Transposition flap, rotation flap, removal of osteomyelitic bone and skin grafts were done. Among 16 cases, 3 cases (18.75%) were skin grafted, 6 cases (37.5%) were reconstructed with transposition flaps, 5 cases (31.25%) were reconstructed with rotation flap and 2 cases (12.5%) were reconstructed with skin graft after removal of osteomyelitic outer table of skull bone. The postoperative complications seen in this series includes partial graft loss in 2 cases (skin graft), marginal necrosis in 1 case (transposition flap) and alopecia in 11 cases (in skin graft and transposition flap). There was no alopecia in reconstruction with rotation flap. Rotation flaps brings the best outcome in terms of durability and aesthetic acceptability where it is applicable in comparison to other procedure.Bang Med J (Khulna) 2015; 48 : 3-6
Background: Ponseti's technique has become the standard and most effective treatment modality for correction of Congenital Talipes Equinovarus (CTEV) in newborn. With time, little modification has been done in the classic technique.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.